Abstract
The pyrido[4,3-b]carbazole alkaloids, ellipticine and olivacine, have been attracting considerable interest since many years due to their pronounced antitumour activity. Among the large number of structural variations of these lead compounds which have been performed in search of new agents with enhanced pharmacological profiles, a remarkable proportion of work has been devoted to the synthesis of diazine-fused carbazoles as "aza" analogues (in a broader sense) of the natural products. The present article will give a detailed overview of the literature from the past two decades in this field of medicinal heterocyclic chemistry.
Keywords: N-benzyl-substituted pyridazinone, bromobenzene, antitumour, DNA replication, Diels-Alder approach, intramolecular inverse-electron-demand
Current Organic Chemistry
Title: Diazine Analogues of the Pyridocarbazole Alkaloids
Volume: 10 Issue: 3
Author(s): Norbert Haider
Affiliation:
Keywords: N-benzyl-substituted pyridazinone, bromobenzene, antitumour, DNA replication, Diels-Alder approach, intramolecular inverse-electron-demand
Abstract: The pyrido[4,3-b]carbazole alkaloids, ellipticine and olivacine, have been attracting considerable interest since many years due to their pronounced antitumour activity. Among the large number of structural variations of these lead compounds which have been performed in search of new agents with enhanced pharmacological profiles, a remarkable proportion of work has been devoted to the synthesis of diazine-fused carbazoles as "aza" analogues (in a broader sense) of the natural products. The present article will give a detailed overview of the literature from the past two decades in this field of medicinal heterocyclic chemistry.
Export Options
About this article
Cite this article as:
Haider Norbert, Diazine Analogues of the Pyridocarbazole Alkaloids, Current Organic Chemistry 2006; 10 (3) . https://dx.doi.org/10.2174/138527206775473913
DOI https://dx.doi.org/10.2174/138527206775473913 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Chemistry and Biology of Carbohydrates
Carbohydrates are one of the most abundant natural products and are considered to be extremely important biomolecules for their ever-increasing impact on chemistry and biology. Their role in several important biological processes, notably energy storage, transport, modulation of protein function, intercellular adhesion, malignant transformation, signal transduction, viral, and bacterial cell ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Aging Property of G2013 Molecule as a Novel Immunosuppressive Agent on Enzymatic and Non-Enzymatic Oxidative Stress Determinants in Rat Model
Current Drug Discovery Technologies New Multidrug Resistance Reversal Agents
Current Drug Targets Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Thiazole Containing Nitrogen Mustards: Synthesis, Structural Evaluation, Cytotoxicity and DNA Binding Studies
Letters in Drug Design & Discovery 2D QSAR and Virtual Screening based on Pyridopyrimidine Analogs of Epidermal Growth Factor Receptor Tyrosine Kinase
Current Computer-Aided Drug Design Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
Current Cancer Drug Targets Patents on Nanoparticulate Drug Delivery Systems - A Review
Recent Patents on Drug Delivery & Formulation Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Current Pharmaceutical Design Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Hydrogels: A Journey from Diapers to Gene Delivery
Mini-Reviews in Medicinal Chemistry Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Vascular Disrupting Agents (VDAs) in Anticancer Therapy
Current Clinical Pharmacology Disulfide Linkage: A Potent Strategy in Tumor-Targeting Drug Discovery
Current Medicinal Chemistry Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Current Cancer Drug Targets Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Corticotropin Releasing Factor (CRF) Peptide Family and their Receptors: Divergent Actions Influencing Human Physiology
Current Genomics NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer
Current Medicinal Chemistry Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery